Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Health

>> CHEMOTHERAPY Latest News

22 HOURS AGO - Washington Times

A Must Read - Share

Family going bald to honor young cancer patient who died

GEORGETOWN, Ind. (AP) - Harper Wehneman didn't have a choice. The medicine required to treat her metastatic kidney cancer would cause hair loss. Once the chemotherapy began, her light brown locks fell out in clumps. Soon after, the young girl's head was as smooth as velvet. The treatments proved too ...

Tags: Family going bald to honor young cancer patient who died,  Chemotherapy Latest News

MAR 03, 2015 - Health Canal

A Must Read - Share

MD Anderson Study Shows Why Some Brain Cancers Resist Treatment

Scientists at The University of Texas MD Anderson Cancer Center may have discovered why some brain cancer patients develop resistance to standard treatments including radiation and the chemotherapy agent temozolomide.

Tags: MD Anderson Study Shows Why Some Brain Cancers Resist Treatment,  Chemotherapy Latest News

MAR 03, 2015 - Health Canal

A Must Read - Share

TSRI Scientists Find Clues to Cancer Drug Failure

LA JOLLA, CA – Cancer patients fear the possibility that one day their cells might start rendering many different chemotherapy regimens ineffective. This phenomenon, called multidrug resistance, leads to tumors that defy treatment.

Tags: TSRI Scientists Find Clues to Cancer Drug Failure,  Chemotherapy Latest News

MAR 02, 2015 - Huffington Post

A Must Read - Share

Watch The Beautiful Love Story Of A Young Couple Fighting Cancer

"We were living a normal life, and the next thing you know, boom, Allen has a brain tumor." Linda Sim was just 25 when she got the news about her boyfriend Allen Chou's diagnosis, when he was just 27. Chou initially responded well to chemotherapy treatment, Sim says in the video above, part of Frontline's Being Mortal series, but eventually, ...

Tags: Watch The Beautiful Love Story Of A Young Couple Fighting Cancer,  Chemotherapy Latest News

MAR 01, 2015 - Yahoo! News

A Must Read - Share

Amgen says Kyprolis doubles progression-free survival vs Velcade

Amgen Inc's Kyprolis helped patients with relapsed multiple myeloma live twice as long before their blood cancer worsened compared to a regimen containing rival drug Velcade, according to an interim analysis announced by the company on Sunday. Kyprolis, the centerpiece of Amgen's nearly $10 billion acquisition of Onyx Pharmaceuticals in 2013, had sales last year of $331 million. Velcade, sold ...

Tags: Amgen says Kyprolis doubles progression-free survival vs Velcade,  Chemotherapy Latest News